The Others segment is valued at USD 828.56 million in 2025, accounting for an 8.5% share, and is projected to reach USD 1,146.23 million by 2034, growing at a CAGR of 3.6%. This category includes neurosurgery, orthopedics, and ENT procedures that increasingly rely on accurate fluid control and irrigation systems.
Top 5 Major Dominant Countries in the Others Application
-
United States: USD 285.76 million in 2025, 34.5% share, projected to reach USD 395.72 million by 2034 at a CAGR of 3.6%. Broader use in outpatient surgical units strengthens growth.
-
Germany: USD 122.38 million in 2025, 14.7% share, reaching USD 170.06 million by 2034 with a CAGR of 3.7%. Increasing orthopedic procedures support steady market expansion.
-
China: USD 106.22 million in 2025, 12.8% share, rising to USD 150.01 million by 2034 with a CAGR of 3.8%. Demand is boosted by growing ENT and neuro procedures in urban hospitals.
-
Japan: USD 94.05 million in 2025, 11.3% share, reaching USD 132.97 million by 2034 at a CAGR of 3.8%. Technological advancements in surgical irrigation systems strengthen segment presence.
-
India: USD 71.42 million in 2025, 8.6% share, expected to reach USD 101.84 million by 2034 with a CAGR of 3.9%. Rapid adoption in emerging hospital networks drives consistent growth